Back to Search
ROBERTO PILI, MD
MD
Medical Oncology Physician
NPI: 1669419867IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
01075267A(IN)252439(NY)
CMS Specialties
PrimaryMEDICAL ONCOLOGY
Education
OTHER
Class of 1989
Research & Publications (20)
Recent investigations of histone deacetylase inhibitors in renal cell carcinoma.
PMID 19521328·Clin Adv Hematol Oncol·2009
8-other
Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma.
PMID 19487381·J Clin Oncol·2009
3-trial
NCCN clinical practice guidelines in oncology: testicular cancer.
PMID 19555582·J Natl Compr Canc Netw·2009
6-review
VEGF recruits lactosylceramide to induce endothelial cell adhesion molecule expression and angiogenesis in vitro and in vivo.
PMID 19219548·Glycoconj J·2009
7-preclinical
NCCN clinical practice guidelines in oncology: kidney cancer.
PMID 19555584·J Natl Compr Canc Netw·2009
6-review
Concordance of cancer patients' function, symptoms, and supportive care needs.
PMID 19657724·Qual Life Res·2009
8-other
Vinflunine in platinum-pretreated patients with locally advanced or metastatic urothelial carcinoma: results of a large phase 2 study.
PMID 19536904·Cancer·2009
3-trial
Targeting tumor angiogenesis with histone deacetylase inhibitors.
PMID 19111391·Cancer Lett·2009
6-review
Combination strategy targeting the hypoxia inducible factor-1 alpha with mammalian target of rapamycin and histone deacetylase inhibitors.
PMID 18519793·Clin Cancer Res·2008
8-other
Phase II trial of docetaxel with rapid androgen cycling for progressive noncastrate prostate cancer.
PMID 18565882·J Clin Oncol·2008
3-trial
Feasibility and potential cost/benefit of routine isoflurane sedation using an anesthetic-conserving device: a prospective observational study.
PMID 18811990·Respir Care·2008
4-observational
Reproducibility of tumor blood flow quantification with 15O-water PET.
PMID 18832120·J Nucl Med·2008
8-other
A phase II trial of 17-allylamino-17-demethoxygeldanamycin in patients with hormone-refractory metastatic prostate cancer.
PMID 19047126·Clin Cancer Res·2008
3-trial
Symptoms, supportive care needs, and function in cancer patients: how are they related?
PMID 18493865·Qual Life Res·2008
8-other
Phase I study of MGCD0103 given as a three-times-per-week oral dose in patients with advanced solid tumors.
PMID 18421048·J Clin Oncol·2008
3-trial
Population pharmacokinetic-pharmacodynamic model of the vascular-disrupting agent 5,6-dimethylxanthenone-4-acetic acid in cancer patients.
PMID 18381951·Clin Cancer Res·2008
3-trial
Digoxin and other cardiac glycosides inhibit HIF-1alpha synthesis and block tumor growth.
PMID 19020076·Proc Natl Acad Sci U S A·2008
7-preclinical
Intravenous bevacizumab causes regression of choroidal neovascularization secondary to diseases other than age-related macular degeneration.
PMID 18054887·Am J Ophthalmol·2008
5-case
The N-Myc down regulated Gene1 (NDRG1) Is a Rab4a effector involved in vesicular recycling of E-cadherin.
PMID 17786215·PLoS One·2007
8-other
Platelets take up the monoclonal antibody bevacizumab.
PMID 17855648·Clin Cancer Res·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 45 SPINDRIFT DR
WILLIAMSVILLE, NY 14221 - Phone
- (716) 422-5422
Quick Facts
- NPI
- 1669419867
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 37
- Publications
- 20
Are you this provider?
Claim Your Profile